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Abstract
Malaria remains one of the leading causes of death worldwide, despite decades of public
health efforts. The recent commitment by many endemic countries to eliminate malaria
marks a shift away from programs aimed at controlling disease burden towards one that em-
phasizes reducing transmission of the most virulent human malaria parasite, Plasmodium
falciparum. Gametocytes, the only developmental stage of malaria parasites able to infect
mosquitoes, have remained understudied, as they occur in low numbers, do not cause dis-
ease, and are difficult to detect in vivo by conventional methods. Here, we review the trans-
mission biology of P. falciparum gametocytes, featuring important recent discoveries of
genes affecting parasite commitment to gametocyte formation, microvesicles enabling par-
asites to communicate with each other, and the anatomical site where immature gameto-
cytes develop. We propose potential parasite targets for future intervention and highlight
remaining knowledge gaps.
Introduction
Over 200 million people contract malaria each year, with nearly half of the global population at
risk of infection [1]. Of the five malaria parasite species that infect humans, Plasmodium falcip-
arum is responsible for the majority of the 600,000 malaria-related deaths occurring every year
[1]. Despite repeated calls for global malaria eradication in the past century, the local and re-
gional elimination programs that underlie this larger goal have proven to be challenging. In
particular, the lack of an effective vaccine and the emergence of drug-resistant parasites sug-
gests that interventions targeting the symptom-causing (asexual) parasite forms are insufficient
to interrupt transmission. Indeed, many P. falciparum infections are not severe, and in highly
endemic regions, most cause no symptoms at all but can nevertheless contribute to malaria
transmission. The importance of these asymptomatic infections, in particular submicroscopic
ones, for onward transmission remains controversial [2], although evidence suggests they con-
tribute significantly [2–5]. With a view to defining the human infectious reservoir, research
into the basic biology of parasite transmission, a process that remains poorly understood, has
been recently reinvigorated.
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The life cycle of P. falciparum is highly complex, involving several developmental stages in
both the human host and the mosquito vector (Fig 1). The mature asexual blood stages within
the human host are responsible for all the clinical symptoms of malaria, though they are unable
to infect the mosquito and complete the parasite’s life cycle. Only the nonreplicating sexual
blood stages of the parasite (male and female gametocytes), which circulate at much lower den-
sities and peak at different times during infection than asexual parasites, are capable of devel-
oping in the mosquito vector and causing onward infection. Not only are the developmental
processes and dynamics of gametocytes in the human poorly understood, making it difficult to
correlate asexual parasitemia with gametocyte density [6], but also the association between ga-
metocyte density in the blood and infectivity to mosquitoes appears to be nonlinear [7]. Unlike
directly transmitted pathogens, therefore, parasite load per se is a poor indicator of infectious-
ness, and we currently lack efficient methods to measure the human infectious reservoir that
underlies malaria transmission.
In order to target interventions during elimination programs and to design new transmis-
sion-blocking vaccines or drugs, we need a deeper understanding of the complex processes that
underlie human infectiousness. Here, we will discuss recent advances in P. falciparum gameto-
cyte biology, describe key knowledge gaps (Box 1) that must be addressed in order to direct fu-
ture interventions, and identify potential parasite targets that may be explored for development
of drugs and vaccines aiming to interrupt malaria transmission. We follow the parasite from
commitment along the sexual pathway to hidden development in the human host and finally
to transmission to the mosquito vector.
Developmental Decisions: To Proliferate or to Transmit?
The first step in the transmission of malaria parasites from the human host to the mosquito
vector is the formation of male and female gametocytes. At this juncture, the parasite exhibits
adaptive strategies with respect to two aspects of gametocyte formation: (i) the proportion of
asexual parasites that develop into gametocytes, referred to as the conversion rate [8] and (ii)
the ratio of male to female gametocytes formed [9]. The precise point within an individual par-
asite’s life cycle at which it commits to the sexual pathway and determines the ensuing gameto-
cyte sex ratio remains unclear but is thought to occur prior to merozoite formation [10–13].
The molecular mechanism responsible for the switch from asexual to sexual development has
remained elusive until the recent identification of a master gene, ap2-g, responsible for trigger-
ing a transcriptional cascade that initiates gametocytogenesis in both P. falciparum [14] and P.
berghei [15], a malaria parasite of rodents (Box 2). This conserved member of the AP2-family
of transcription factors appears to be generally epigenetically silenced in asexual parasites by P.
falciparum histone deacetylase 2 (PfHda2) and P. falciparum heterochromatin protein 1
(PfHP1) but could be prone to stochastic activation, leading to the low level of “background”
gametocyte formation commonly observed in vitro (Fig 2) [16,17]. Potential upstream media-
tors of the AP2 master switch include the schizont expressed proteins P. falciparum gametocyte
development 1 (Pfgdv1) and Nima-related kinase (Pfnek4), of which the former has proven to
be crucial for gametocyte formation [18,19]. At a population level, the timing of gametocyte ap-
pearance in asymptomatic and symptomatic infections is poorly understood.
Beyond this baseline rate of gametocyte formation, environmental modulation or “stress” (a
poorly defined term used to indicate a variety of external factors detrimental to the parasite)
has been reported to cause additional asexual parasites to commit to the sexual pathway
[20,21]. A commonly used method to produce gametocytes has been developed based on this
hypothesis [22] but has not been formally tested for an effect on conversion rate. It was thought
that some unidentified parasite-derived factor found in this conditioned medium provides a
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Fig 1. Life cycle of Plasmodium falciparum. The malaria parasite is transmitted to the human host when an infected female Anophelesmosquito takes a
blood meal and simultaneously injects a small number of sporozoites into the skin. After reaching the liver, the sporozoites invade hepatocytes in which they
develop into a liver schizont and replicate asexually. After about seven days of liver stage development, each infected hepatocyte releases up to 40,000
merozoites that enter the peripheral blood stream. Once in the blood stream, merozoites quickly invade circulating red blood cells (RBCs), thereby initiating
the repeated asexual replication cycle. Over the course of 48 hours, the parasite progresses through the ring and the trophozoite stages before finally
replicating into 8–32 daughter merozoites at the schizont stage (schizogony). At this point, the parasitized RBC (pRBC) ruptures and releases merozoites
into circulation, commencing another round of asexual replication. Mature asexual stages that display increased stiffness, trophozoites and schizonts,
adhere to the vasculature in various organs, which allows them to avoid splenic clearance. During each cycle, a small subset of parasites divert from asexual
replication and instead produce sexual progeny that differentiate the following cycle into male and female sexual forms, known as gametocytes. A subset of
parasites (see possible scenarios in Fig 4) leave the peripheral circulation and enter the extravascular space of the bone marrow, where gametocytes mature
and progress through stages I–V over the course of eight to ten days (gametocytogenesis). Although evidence suggests that the bone marrow is the primary
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stress signal that causes a subset of parasites to withdraw from the recurrent asexual replication
and instead form gametocytes [23]. Microvesicles, derived from the membrane of parasitized
red blood cells (pRBCs), have recently been shown to be the critical factor in conditioned
media capable of inducing increased conversion to gametocytes [24,25]. Other putative triggers
such as elevated levels of immature RBCs, serum, and immune cells from naturally infected do-
nors have yet to be confirmed (Box 3, Fig 2) [6,26–29]. While the precise pathway of the micro-
vesicle-mediated initiation of gametocytogenesis remains unresolved, it may occur via AP2-G
or another member of this family of transcription factors. Microvesicles seem to be a method
by which parasites communicate, initiating a response to high parasitemia or other unfavorable
conditions and enhancing the prospect of rapid transmission to a new host [24,25]. A sensing
mechanism of this type is likely to be of particular importance for pathogens that cause long,
chronic infections, as they need to adapt to fluctuations in the host environment. Indeed, an-
other protozoan parasite causing chronic infections, Trypanosoma brucei, has a density sensing
mechanism associated with a life cycle switch [30–32].
P. falciparum is unique among Plasmodium species in its low epigenetic conversion rate in
vitro [8,33] and extended gametocyte maturation time [34,35]. While conversion rates cannot
be directly quantified during natural infections, the gametocyte density in experimental P. fal-
ciparum infections is often very low [6,36,37], consistent with conversion rates of 1% to 5% of
pRBCs in quantitative models [38,39] and low levels during in vitro experiments under nonin-
ducing culture conditions [8,40]. Several plausible hypotheses have been proposed for “repro-
ductive restraint,” the observed low gametocyte density in vivo [41], such as minimizing the
immune response directed specifically towards gametocytes or reducing the parasite burden in
mosquitoes [41,42]. These hypotheses are consistent with the observed low gametocyte density
in vivo, although neither are specific to low conversion rates, since low gametocyte densities
can result from both very low and very high conversion rates [41]. In the latter case with high
conversion rates, the asexual parasite population is not able to grow to high density, limiting
the absolute level of gametocytes possible. Alternatively, competition between parasite geno-
types within the human host may generate a low conversion rate in P. falciparum, if survival
through asexual growth is prioritized over gametocyte production [41]. Although studies with
the rodent malaria parasite P. chabaudi, with its shorter gametocyte maturation period, show
evidence of a reduced gametocyte conversion rate in the presence of multiple genotypes [43–
45], there is no evidence of reduced conversion between genotypes of human Plasmodium spe-
cies. Mixed infections, however, between P. falciparum and P.malariae show evidence of in-
creased gametocyte production [46], consistent with enhanced conversion to gametocytes
during stress.
The gametocyte sex ratio is another important developmental decision that varies among P.
falciparum parasites [47,48] and could provide a target for transmission-reducing interven-
tions. Parasites ensure that fertilization will succeed within the mosquito through production
of a sufficient number of male microgametes to fertilize all the female macrogametes. The ratio
of their precursors, male and female gametocytes, has been well studied theoretically for
location of gametocyte maturation, some immature gametocytes have been observed elsewhere in the human body, such as in the spleen. By stage V, male
and female gametocytes re-enter peripheral circulation, in which they become competent for infection to mosquitoes. Once ingested by a mosquito, male and
female gametocytes rapidly mature into gametes (gametogenesis). Within the midgut, the male gametocyte divides into up to eight flagellated microgametes
(exflagellation), whereas the female gametocyte develops into a single macrogamete. Fertilization of a macrogamete by a microgamete results in the
formation of a zygote, which undergoes meiosis and develops into an invasive ookinete that penetrates the mosquito gut wall. The ookinete forms an oocyst
within which the parasite asexually replicates, forming several thousand sporozoites (sporogony). Upon oocyst rupture, these sporozoites migrate to the
salivary glands, where they can be transmitted back to the human host during a blood meal. Asexual parasites (in RBCs) are represented in pale yellow,
sexual parasites in green.
doi:10.1371/journal.ppat.1004871.g001
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Apicomplexan parasites [45,49,50], and in particular for Plasmodium [45,51,52]. Evolutionary
theory suggests that sexual differentiation will be biased towards production of female
Box 1. Knowledge Gaps
Commitment
• What factors activate the Apicomplexan Apetala 2 (ApiAP2)-mediated sexual conver-
sion pathway (Fig 2)?
• How are stress and the microvesicle pathway linked to epigenetic switch rates (Section
2)?
• Which components within microvesicles modulate sexual conversion (Box 3)?
• What drives reproductive restraint in P. falciparum, other Plasmodia, and Hemospori-
dia (Section 2)?
• What determines the sex ratio, and how is it modulated (Section 2)?
Sequestration
• How do gametocytes come to be in the bone marrow (Section 3, Fig 4)?
• Do sexually committed merozoites preferentially invade young RBCs, whether reticu-
locytes in the vasculature or RBC progenitor cells in the extravascular compartment of
the bone marrow (Fig 4)?
• Does the presence of parasites and/or gametocytes in the bone marrow induce patholo-
gy of the hematopoietic system, such as dyserythropoiesis (Section 3)?
• Is the bone marrow associated with immune tolerance, preventing immune recogni-
tion of parasites (Section 3)?
• How does the mature (stage V) gametocyte exit the bone marrow and return to circula-
tion? Can the parasite modulate the timing of exit (Section 3, Fig 4)?
Transmission
• What is the best way to detect and measure infectious gametocytes (Section 4)?
• What is the contribution of subdermal localization and aggregation of mature gameto-
cytes towards infection (Section 4)?
• How can gametocyte load be used to predict infectiousness to feeding mosquitoes (Sec-
tion 4)?
• How do the outcomes of feeding assays relate to human infectious reservoir (Section
4)?
• What immune responses exist towards different stages of gametocytes in the human
(Section 4)?
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gametocytes to ensure an equal ratio of micro- and macrogametes (since male gametocytes
form up to eight microgametes upon activation in the mosquito midgut, Fig 1) [53]. Intriguing-
ly, evolutionary theory suggests that the parasites would benefit from modulation of their sex
ratio, increasing the proportion of male gametocytes when there is greater opportunity for out-
breeding during mixed infections in the mosquito midgut [54]. Indeed, elevated fractions of
male P. falciparum gametocytes have been observed in infections comprised of multiple geno-
types as compared to single genotype infections [55]. Although it has been suggested that mer-
ozoites from a single schizont are destined to form either all male or all female gametocytes
[12,13], the same studies actually observed mixed progeny emerging from the same schizont
[10–12]. The developmental mechanisms underlying the shift in population-level gametocyte
sex ratios are only beginning to be elucidated, with recent work demonstrating the requirement
of Pfmdv1 [56] and PfPuf2 [57] for male gametocyte development. With improvements in de-
tection methods such as single-cell analyses, it will be possible to revisit this and other impor-
tant developmental questions.
Recent breakthroughs in our understanding of the molecular mechanisms responsible for
commitment to the sexual pathway offer new insights into ways to obstruct or prevent infec-
tiousness to mosquitoes [14,15,18,24,25]. The identification of a transcriptionally regulated
mechanism responsible for sexual commitment provides an opportunity to reduce or even ab-
rogate the stochastic activation of the sexual pathway by blocking these key molecular players
(Fig 2). Moreover, the discovery of how parasites communicate (Box 3), conceivably about con-
ditions that are unfavorable for asexual growth, has opened up opportunities to specifically
Box 2. Epigenetic Control of Gametocyte Formation
Prior to the discovery of the Apicomplexan AP2 (ApiAP2) family of DNA-binding pro-
teins, it was thought that Plasmodium parasites had a minimal set of transcription factors
[101]. ApiAP2 proteins have been found to regulate a variety of developmental processes
along the parasite cycle, including ookinete formation [102], sporozoite maturation
[103], and development within hepatocytes [104]. AP2-G, a conserved member of the
ApiAP2 transcription factor family, was recently identified as an essential regulator con-
trolling the switch from asexual to sexual development in both P. falciparum [14] and P.
berghei [15]. In P. falciparum, the Pfap2-g locus appears to be in an epigenetically si-
lenced state in asexual parasites but could be prone to stochastic activation explaining
the commonly observed low level of gametocyte formation under standard, noninducing
culture conditions (Fig 2) [14]. Interestingly, recent evidence suggests that the expression
of Pfap2-g could be mutually exclusive with that of var genes, the gene family encoding
the major asexual surface ligand PfEMP1 responsible for asexual sequestration [14]. In-
deed, PfHda2, an important histone-modifying enzyme involved in P. falciparum gene
silencing, modulates not only expression of multigene families such as var, stevor, and
rifs, but also sexual commitment by promoting transcriptional silencing of Pfap2-g [17].
Similarly, PfHP1, a regulator of heritable gene silencing, controls the mutually exclusive
expression of antigenically varying genes and also regulates sexual conversion by main-
taining Pfap2-g in an epigenetically silent state [16]. Taken together, these novel findings
indicate that the decision between continuing to proliferate asexually and differentiating
into nondividing but transmissible gametocytes is under transcriptional and epigenetic
control and suggest a link between transmission and virulence.
PLOS Pathogens | DOI:10.1371/journal.ppat.1004871 June 18, 2015 6 / 17
target sexual commitment by preventing parasite communication. For example, it may be pos-
sible to target parasite-derived microvesicles for vaccines, thereby blocking their ability to en-
hance sexual conversion rates.
Fig 2. Commitment to sexual maturation. During each asexual cycle within the human blood, a small proportion of parasites cease to replicate asexually
and instead produce sexual progeny that develop into nonreplicating gametocytes, capable of onward transmission to the mosquito vector. Commitment to
the sexual pathway occurs at a low “baseline” rate during each asexual replication cycle [14,15], and the decision to switch is thought to be made prior to
schizogony during the previous asexual replication cycle [10–12]. The switch to gametocytogenesis is governed by the essential transcription factor PfAP2-G
(Box 2), which is epigenetically controlled byPfHda2 and PfHP1 [16,17]. PfHda2 likely promotes transcriptional silencing by removing acetyl groups on
histones, thereby allowing methylation of histone 3 lysine 9 (H3K9). PfHP1 may subsequently bind H3K9me, leading to heterochromatin formation and
Pfap2-g repression. The perinuclear protein Pfgdv1 is another key player that likely operates upstream of PfAP2-G. Pfgdv1 is expressed in a subset of
schizonts, is associated with an increased expression of genes involved in early gametocytogenesis, and has been shown to be critical for gametocyte
production [18]. The Nima-related kinase Pfnek4may also play a role in sexual commitment, as the kinase is expressed in a subpopulation of schizonts that
display a higher sexual conversion rate [19]. Pfnek4 is, however, not strictly gametocyte specific and can be genetically deleted without affecting gametocyte
formation [19]. Although constitutively silenced in asexual parasites, Pfap2-g could be prone to stochastic activation, resulting in a low level of gametocyte
formation. Once initiated, the transcription of Pfap2-gmay be further activated via a positive feedback loop. The baseline conversion rate can be altered by
various factors: those that are derived from the parasites themselves (found within conditioned medium from high-parasitemia in vitro cultures) and those that
are exogenous (antimalarial drugs, anemia, elevated reticulocyte levels, and host immune factors). Enhanced conversion by external factors is extensively
reviewed elsewhere [27]. It has recently been demonstrated that the conditioned medium effect is the result of cellular communication within the parasite
population via pRBC-derived microvesicles (Box 3) [24,25].
doi:10.1371/journal.ppat.1004871.g002
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Gametocyte Sequestration: Where Do They Hide?
Gametocytes are difficult to quantify in vivo since they sequester in tissues during the majority
of their maturation [58–60]. Some of the most detailed in vivo dynamical data come from the
early 20th century when malaria was used as a therapy for tertiary neurosyphilis [36–39]. Para-
site and gametocyte densities were recorded daily for each patient with some infections lasting
for hundreds of days [36]. In these infections, the peak density of mature gametocytes occurred
around day 40 of patent parasitemia, approximately 13 days after the peak in asexual parasite-
mia (Fig 3), consistent with in vitro experiments in which gametocytes mature in eight to ten
days and with previous theoretical work [61]. In some infections, gametocytes appeared as
early as 13 days post–sporozoite inoculation, suggesting that gametocytes can form immediate-
ly upon release of merozoites from the liver into the blood stream (Fig 3).
Several studies have observed immature gametocytes in the human bone marrow
[59,60,62], but not in highly vascularized organs such as the heart, brain, and placenta [63–66],
a strikingly different pattern from the sequestration of asexual stages. A recent quantitative
analysis further confirmed the enrichment of immature gametocytes in bone marrow [67], al-
though a secondary reservoir in the spleen could not be excluded. In addition to the distinct
anatomical sequestration sites of asexual and gametocyte parasites, asexual pRBCs adhere to
vascular endothelial cells but remain in the vasculature while some of the immature gameto-
cytes develop in the extravascular space of the human bone marrow, a site where hematopoietic
stem cells mature into RBCs [67,68]. Within this space, most gametocytes were found in close
association with erythroblastic islands, structures that facilitate the development of cells of the
erythroid lineage [69]. Interestingly, conditions such as anemia and dyserythropoiesis are asso-
ciated with elevated gametocyte levels, demonstrating a potential interaction between gameto-
cytes and the production of healthy RBCs within the hematopoietic system [70]. Despite the
observed enrichment of gametocytes in the human bone marrow, successful in vitro culture of
gametocytes demonstrates that their maturation does not require conditions unique to the
bone marrow and is possible in both mature and immature RBCs.
Box 3. Communication between Parasites
Despite the ubiquitous in vitro usage of parasite-conditioned medium to induce gameto-
cyte formation, it was unknown until recently that microscopic vesicles in conditioned
media represent a critical factor responsible for the observed increase in gametocyte for-
mation [24,25]. Microvesicles are released by both uninfected and parasitized RBCs, al-
though the latter release about ten times more per cell and are the only ones capable of
uptake of microvesicles [24]. Interestingly, recent work demonstrated that pRBC-derived
microvesicles promote sexual differentiation, arguing that parasites are able to sense
their environment and respond accordingly [24,25]. The identity of the factor(s) in
microvesicles responsible for stimulating the increased sexual commitment remains elu-
sive, but it must either directly or indirectly affect the transcriptional program of the par-
asite, potentially through the Pfgdv1/PfHda2/PfHP1/ApiAP2 pathway (Box 2 and Fig 2).
Indeed, internalized microvesicles were observed in close association with the parasite
nucleus [24], and transfer of plasmid DNA into the parasite nucleus has been shown
[25]. The ability of the parasites to communicate is likely of great importance for the par-
asite to optimize the balance between transmission success and persistence.
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There are potential benefits for extravascular sequestration of gametocytes: presence of a
nutrient-rich environment with an abundance of young RBCs and potential reprieve from
human immune responses. As gametocytes appear to thrive in blood rich with young RBCs
[26,71–74], maturation within this main site for RBC production provides the parasites with
an ample source of young host cells to invade. Although increased levels of young RBCs are as-
sociated with enhanced gametocyte densities, it remains unclear whether sexually committed
Fig 3. Dynamics of P. falciparum in malaria therapy patients. (A) The first appearance of patent
parasitemia (pale yellow) generally occurs at day 11 following an infectious bite, while gametocytemia (green)
arises 11 days later because of the extended development and sequestration of P. falciparum gametocytes.
Mosquitoes (pink) first become infected three days after the appearance of gametocytes. (B) The separation
of timing of peaks in parasitemia (pale yellow), gametocytemia (green), and mosquito infection (pink) are
similar to their first appearance but delayed by a week. (C) The period between the first appearance of patent
parasitemia and gametocytemia (red) centers around 11 days, with some infections requiring as many as 20
days before patent gametocytemia after parasitemia has been observed. Mosquito infection is first observed
in the initial days following patent gametocytemia (blue) but may not happen until weeks later. (D) The period
between the peak of asexual parasitemia and gametocytemia (red) follows a similar appearance to the timing
between initial appearances in C, but with more infections showing weeks between the peak in parasitemia
and gametocytemia. The peak in mosquito infection (blue), however, occurs shortly after the peak in
gametocytemia. n = 106. Patients without gametocytes or mosquito infection do not contribute to the time of
appearance or peak of gametocytes and mosquito infection, respectively. Data in A and B are smoothed
using a moving average including 5 consecutive days. (Data are courtesy of Dr. William E. Collins and Dr.
Geoffrey M. Jeffery.)
doi:10.1371/journal.ppat.1004871.g003
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merozoites preferentially invade RBC progenitor cells [28,67]. During development in the bone
marrow, P. falciparum gametocytes may procure protection from the immune system. Recent
in vivo data indicate that gametocytes are significantly less susceptible than asexual parasites to
phagocytosis in the bone marrow [67,68], confirming previous in vitro data [75]. Similarly, a
recent report indicated that latentMycobacterium tuberculosis resides in the human bone mar-
row mesenchymal cells and hypothesizes that the bone marrow functions as a protected niche
for the nonreplicating form of the bacteria [76].
It is currently unclear how immature gametocytes reach the bone marrow: whether gameto-
cyte commitment and invasion occurs in the extravascular environment (causing gametocyte
progeny to be born there) or young gametocytes home to the bone marrow and subsequently
enter the extravascular space (Fig 4). As it has been demonstrated that gametocytes cannot
cytoadhere efficiently to endothelial cells [77,78], a switch in cellular rigidity during both the
initial and final stages of gametocyte maturation provides a potential explanation for how im-
mature gametocytes are able to enter and mature ones are able to exit the bone marrow
Fig 4. Gametocyte sequestration in the bonemarrow. Several pathways may explain the enrichment of gametocytes in the extravascular compartment of
the bone marrow and their subsequent release. (A) Asexual pRBCs adhere to the bone marrow endothelium and transmigrate into the bone marrow
extravascular space. Once inside the bone marrow, asexual parasites either continue maturation producing asexual progeny or commit to production of
gametocytes in the next cycle. (B) Sexually committed pRBCs specifically “home” to the bone marrow sinusoids by adhering to the bone marrow
endothelium, after which they transmigrate into the extravascular space. Once in the extravascular compartment, the sexually committed pRBCs undergo
schizogony resulting in the release of gametocyte-fated merozoites, which invade the abundant erythroid progenitor cells and for the most part develop
attached to erythroblastic islands. (C) Similarly, sexually committed pRBCs could home to the bone marrow but not transmigrate into the extravascular
space, perhaps because of their adhesion to the bone marrow endothelial cells or their low deformability. Upon schizont rupture within the bone marrow
vasculature, the gametocyte-fated merozoites could enter the extravascular compartment and invade the erythroid progenitor cells. Merozoites from
noncommitted asexual pRBCs may also enter the bone marrow and invade erythroid progenitor cells, either continuing asexual replication or forming
gametocyte-fated merozoites the following cycle (not pictured). (D) Sexually committed pRBCs may not display a binding preference for bone marrow
endothelial cells. Instead, sexually committed pRBCs may be formed in various asexual sequestration sites throughout the body with subsequent invasion of
gametocyte-fated merozoites occurring in circulation, in a similar fashion to asexual invasion. Following intravascular invasion, however, the young
gametocytes home to the bone marrow sinusoids and adhere to the endothelial cells, after which they transmigrate into the extravascular space. (E)
Immature gametocytes display a markedly increased cellular rigidity [79–81]. Upon maturation, however, deformability is rapidly restored, likely allowing the
mature stage V gametocytes to exit the extravascular compartment and return to circulation, where they can be taken up by a feeding mosquito [79–81].
doi:10.1371/journal.ppat.1004871.g004
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extravascular space [79–81]. Indeed rigidity-mediated gametocyte retention in the extravascu-
lar space could serve as a potential mechanism for the extended gametocyte maturation of P.
falciparum.
The sequestration of immature gametocytes from peripheral circulation during their pro-
longed development [58–60] provides potential targets for interventions at multiple points: the
entrance into the extravascular space, the maturation within the bone marrow, and the re-
entry into the peripheral circulation. For example, targeting surface antigens on pRBCs homing
to the bone marrow could prevent parasites from even reaching this site. During development
within the bone marrow, the close association of immature gametocytes with erythroblast is-
lands (Fig 4) may play an important role in their maturation [67], and blocking this interaction
by targeting potential gametocyte surface antigens could hinder proper gametocyte develop-
ment. Drugs that prevent the rigidity switch during the end of maturation could potentially
trap the gametocytes. Elucidation of the mechanistic basis and molecular factors involved in
bone marrow homing, sequestration, and release will likely lead to ways of preventing success-
ful gametocyte maturation and thereby reduce the reservoir of transmissible stages.
Determinants of Infectiousness to the Mosquito Vector
The nonlinear association between different parasite life cycle stages [6]—from asexual para-
sites in the human blood to sporozoites in the salivary glands of the mosquito—makes it diffi-
cult to use molecular data to determine the human infectious reservoir. Upon release from the
extravascular compartment of the bone marrow, mature gametocytes appear to remain in cir-
culation for around six days [38,82] and may require several days in circulation before becom-
ing infectious to the mosquito (Fig 3) [36,83]. While in circulation, mature gametocytes must
pass through microvasculature in the dermis in order to be accessible to feeding mosquitoes
[84], but it remains to be seen whether mature gametocytes aggregate or preferentially localize
in subdermal tissues to increase the likelihood of transmission [85]. Once ingested in a blood
meal, both male and female gametocytes must be present for fertilization to occur. While the
probability of transmission to the mosquito vector generally increases with higher gametocyte
densities [7,86,87], mosquito infection has been observed at submicroscopic gametocyte levels
[2–4,88]. These observations suggest that transmission is highly efficient even at very low ga-
metocyte densities and that quantifying mature gametocytes capable of infecting mosquitoes
remains challenging despite recent advancements in gametocyte detection [89].
Infectiousness of a P. falciparum–infected individual to a mosquito vector is difficult to reli-
ably quantify by molecular measurements because of the low number of gametocytes detectable
in peripheral blood [6,34,88] and the nonlinear relationship between mature gametocyte densi-
ties and oocyst presence in the mosquito [7]. Several different types of feeding assays are cur-
rently employed to measure infectiousness, but only direct skin feeding accurately recapitulates
the environment during a normal blood feed [5]. For ethical reasons, this method is restricted
to older children and adults, excluding the group with the highest prevalence of gametocytes
[6,90,91] and thus limiting the scope of direct feeding as a tool for quantifying the infectious
reservoir on a population level. The direct membrane-feeding assay (DMFA), in which mos-
quitoes feed on blood from a naturally infected gametocyte carrier through a membrane, is
most commonly used, despite the unnatural transmission method [5]. The standard mem-
brane-feeding assay (SMFA), in which mosquitoes are fed on gametocyte-rich cultured blood
through a membrane and dissected to quantify oocyst burden following a gestation period, is
the standard to test transmission-blocking activity in the lab [5,88,92]. SMFA, however, is an
unnatural transmission method and often underestimates the infectivity of gametocytes [5].
Furthermore, all methods assume that the presence and level of oocysts in the mosquito midgut
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is indicative of mosquito infectivity. This relationship was recently demonstrated to be consis-
tent for low-density infections despite a portion of the oocysts failing to release viable sporozo-
ites [93,94]. Even in the cases in which oocysts burst and sporozoites successfully migrate to
the salivary glands, not all bites from an infected mosquito are equally infectious. In general the
heterogeneity in parasite maturation in the mosquito and the lack of standardized protocols
for feeding assays makes it difficult to predict transmission efficiency from gametocyte levels
[5,7].
Quantifying infectivity is also hindered by both human and mosquito immune responses, as
well as competition the parasite encounters within the mosquito vector. The immune system of
the mosquito itself must play a role in elimination of the malaria parasite, although the molecu-
lar determinants of mosquito protection are poorly understood [95,96]. Transmission-blocking
immunity, in which gamete-specific antibodies present in the circulating blood of the human
host are taken up in the blood meal and alter the development of parasites within the mosquito,
potentially contributes to the lack of correlation between gametocytes and transmissibility
[5,97]. Competitive interactions between different pathogens within the mosquito could also
be potential factors affecting parasite development. Initial experiments in which Anopheles
mosquitoes infected with the maternally inherited symbiotic bacteriaWolbachia fed on game-
tocyte cultures have demonstrated thatWolbachia significantly inhibits parasite development,
although by an unknown mechanism [98].
The portion of the parasite life cycle in the mosquito and the bottlenecks experienced during
the transfer of parasites from the human host to the mosquito vector and back have been
touted as the most effective intervention targets for over a century. In addition to conventional
methods such as insecticides to kill mosquitoes and gametocytocidal or sporonticidal drugs to
remove the parasites in the human and vector hosts, novel strategies of intervention are need-
ed. A recent finding that treating mosquitoes with a naturally occurring mosquito hormone
that prevents them from mating may be an alternative way to control mosquito populations as
insecticide resistance spreads [99]. Within individual mosquitoes, compounds, such as kinase
inhibitors or antimicrobial peptides that enhance the mosquito’s ability to fight the parasite,
could reduce the prevalence of parasites within mosquitoes. Competition within the mosquito
is also a promising intervention, following the recent discovery of Anopheles populations natu-
rally infected withWolbachia [100] and the reduction in malaria parasite development ob-
served in experimentally infected Anopheles populations [98].
Conclusion
Reductions in malaria-related morbidity and mortality over the past few decades have shifted
the focus of research from attenuation of disease towards strategies to reduce transmission as
part of elimination and eradication campaigns. Without a highly effective vaccine, combina-
tions of malaria prevention and treatment are required, and the sexual stage of the parasite’s
life cycle represents a key bottleneck and an ideal target for novel strategies. Recent develop-
ments in the basic biology of P. falciparum transmission, including the identification of genes
affecting parasite commitment to gametocyte production, microvesicles enabling the parasites
to communicate among themselves, and the anatomical site where immature gametocytes de-
velop, have led to the identification of novel intervention targets in addition to more estab-
lished transmission-blocking strategies. We highlight key knowledge gaps that need to be
addressed for the successful development of drugs and vaccines that interrupt malaria trans-
mission. More fundamental research on gametocyte biology will enhance not only our under-
standing of the basic principles underlying parasite transmission but also our ability to identify
infectious individuals.
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